Biosynthesis and Fate of Endocannabinoids (Q38593114)

4 September 2017

Biosynthesis and Fate of Endocannabinoids (English)

1 reference

4 September 2017

0 references

Pietro Marini

2

0 references

author name string

Maria Grazia Cascio

series ordinal

1

1 reference

PubMed ID

26408157

4 September 2017

language of work or name

1 reference

1 January 2015

1 reference

Handbook of experimental pharmacology

4 September 2017

1 reference

4 September 2017

231

1 reference

4 September 2017

39-58

1 reference

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

4 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The expanding field of cannabimimetic and related lipid mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

PUFA-derived endocannabinoids: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A structure-activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Chemical characterization of a family of brain lipids that induce sleep

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story...

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Biochemistry of the endogenous ligands of cannabinoid receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Endocannabinoids Part I: molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The endocannabinoid system and its therapeutic exploitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Brain monoglyceride lipase participating in endocannabinoid inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Endocannabinoids, related compounds and their metabolic routes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Endogenous cannabinoids revisited: a biochemistry perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Anandamide uptake explained?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Transport of endocannabinoids across the plasma membrane and within the cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A catalytically silent FAAH-1 variant drives anandamide transport in neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Molecular characterization of human and mouse fatty acid amide hydrolases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Discovery and isolation of anandamide and other endocannabinoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Modulators of endocannabinoid enzymic hydrolysis and membrane transport.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Identification of intracellular carriers for the endocannabinoid anandamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Modulation of anxiety through blockade of anandamide hydrolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Further evidence for the existence of a specific process for the membrane transport of anandamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Activation of N-acylethanolamine-releasing phospholipase D by polyamines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A biosynthetic pathway for anandamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Intracellular trafficking of anandamide: new concepts for signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Evidence for the intracellular accumulation of anandamide in adiposomes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Molecular characterization of a phospholipase D generating anandamide and its congeners

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Novel selective and metabolically stable inhibitors of anandamide cellular uptake

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

More surprises lying ahead. The endocannabinoids keep us guessing

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Characterization of the 5'-sequence of the mouse fatty acid amide hydrolase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The major central endocannabinoid directly acts at GABA(A) receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Cannabinoids and PPARalpha signalling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Endocannabinoid hydrolases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Enzymes for anandamide biosynthesis and metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Transcriptional regulation of the mouse fatty acid amide hydrolase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

A second fatty acid amide hydrolase with variable distribution among placental mammals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-20825-1_2

10.1007/978-3-319-20825-1_2

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26408157